It is noted that the in vitro sensitivity of a certain cancer cell line to growth inhibition by an anti-IGF-1R mAb has been proposed to require a minimal level of IGF-1R expression as well as a functional IGF signaling axis, both of which may contribute to ligand-stimulated proliferation [53]. This evidence concerns the gene IGF1 and cancer.